How iioprocess Innovations Have Laid the Foundation for a Cell-Based Products Revolution.In the first cell therapy special issue of BioProcess International back in 2011,members of the International Society for Cell and Gene Therapy’s (ISCT’s) commercialization committee highlighted the need for cell-processing professionals who prepare bone-marrow and cord-blood products to collaborate with bioprocess engineers in establishing commercially-relevant manufacturing processes for a new wave of cell-based therapies (l). The emerging field of cell and gene therapy presented unique challenges for creating scalable bioprocesses under current good manufacturing practices (CGMPs) to accommodate primary cells with limited expansion potential, many of whichwere adhesion dependent.
展开▼
